Sagimet Biosciences (STU:0O2) Shares Buyback Ratio % : -40.61 (As of May. 08, 2025)

View and export this data going back to 2023. Start your Free Trial

What is Sagimet Biosciences Shares Buyback Ratio %?

Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.

GuruFocus calculates shares buyback ratio using previous shares outstanding minus the current shares outstanding, and then divides by previous shares outstanding. Sagimet Biosciences's current shares buyback ratio was -40.61%.

Sagimet Biosciences Shares Buyback Ratio % Historical Data

The historical data trend for Sagimet Biosciences's Shares Buyback Ratio % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sagimet Biosciences Shares Buyback Ratio % Chart

Sagimet Biosciences Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Shares Buyback Ratio %

Get a 7-Day Free Trial

-3.26

-40.61

Sagimet Biosciences Quarterly Data
	Dec19	Mar20	Dec20	Mar21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Shares Buyback Ratio %	Get a 7-Day Free Trial												-	-39.39	-	-0.88	-

Sagimet Biosciences Shares Buyback Ratio % Calculation

Sagimet Biosciences's Shares Buyback Ratio for the fiscal year that ended in Dec. 2024 is calculated as

Shares Buyback Ratio	=	(Shares Outstanding (EOP) (A: Dec. 2023 )	-	Shares Outstanding (EOP) (A: Dec. 2024 ))	/	Shares Outstanding (EOP) (A: Dec. 2023 )
	=	(22.896	-	32.195)	/	22.896
	=	-40.61%

Sagimet Biosciences's Shares Buyback Ratio for the quarter that ended in Dec. 2024 is calculated as

Shares Buyback Ratio	=	(Shares Outstanding (EOP) (A: Sep. 2024 )	-	Shares Outstanding (EOP) (A: Dec. 2024 ))	/	Shares Outstanding (EOP) (A: Sep. 2024 )
	=	(32.195	-	32.195)	/	32.195
	=	0.00%

Sagimet Biosciences Shares Buyback Ratio % Related Terms

Thank you for viewing the detailed overview of Sagimet Biosciences's Shares Buyback Ratio % provided by GuruFocus.com. Please click on the following links to see related term pages.

Sagimet Biosciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sagimet Biosciences Inc (STU:0O2) » Definitions » Shares Buyback Ratio %

Comparable Companies

Traded in Other Exchanges

SGMT:USA 0O2:Germany

Address

155 Bovet Road, Suite 303, San Mateo, CA, USA, 94402

Website

https://www.sagimet.com

Sagimet Biosciences Inc is a clinical-stage biopharmaceutical company dedicated to developing a portfolio of in-house discovered, selective fatty acid synthase (FASN) inhibitors aimed at treating diseases that arise from dysfunctional lipid metabolism pathways. The company's drug candidate, denifanstat, is an oral, once-daily pill that serves as a selective FASN inhibitor under development for treating nonalcoholic steatohepatitis (NASH). The company functions as a single business segment, focusing on the development and commercialization of therapeutics for MASH and other diseases where FASN plays a pathogenic role.

Sagimet Biosciences Headlines

No Headlines